Although the metal sector currently faces poor earnings and sentiment, there is potential for interest to return with an expected uptick in the economy. Hindalco is recommended as the top pick, with JSPL and NMDC also favourable investments. As for the pharma sector, the strategist suggests selectivity is key and recommends companies such as Sun Pharma, Dr Reddy’s, Ajanta Pharma and Alkem Lab.
